{
  "issued_date": "2012-09-10", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON184434", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2012/061", 
    "Audience": "Healthcare professionals", 
    "Published": "10 September 2012 at 11:30", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "4", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "Field Safety Notice", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con174848.pdf", 
      "filename": "downloads/aff7b2e5a21a86ca33e6030c8e8ea9cb04606c75/con174848.pdf", 
      "original_filename": "con174848.pdf"
    }
  ], 
  "body": "## Device\n\nImplantable cardioverter defibrillator (ICD) leads.  \n  \nRiata and Riata ST \u2013 all silicone coated models.  \n  \nManufactured by St Jude Medical.\n\n## Problem\n\nRisk of inappropriate shock or therapy failure due to wear of lead insulation after implantation.\n\nThese patient follow-up recommendations replace those given previously in MDA/2010/095 and MDA/2011/112.\n\nIn December 2011, the MHRA issued a Medical Device Alert (MDA/2011/112) recommending enhanced patient follow-up for all patients implanted with Riata and Riata ST lead models. At that time the frequency of follow-up was stratified according to lead model. Current evidence suggests that the difference in prevalence of externalised cables between 8Fr and 7Fr lead models is decreasing.\n\nSt Jude Medical has recently issued a [ASSET_TAG](#ASSET0) (155Kb) (dated 13 July 2012) detailing phase I of a Riata lead evaluation study to investigate the prevalence of externalised cables using fluoroscopy. The clinical significance of externalised cables will not, however, be evident until phase II of the study is completed; this is unlikely to be before the end of 2013. For this reason this Medical Device Alert is focusing on detection of early signs of functional lead failure, as these lead models continue to fail at a higher rate.\n\n## Action  \n  \n  * Continue to follow up all patients implanted with Riata or Riata ST ICD lead models to identify any changes in lead performance, according to your own standard procedures (see further advice below). Undertake this:   \n    * at three-month intervals (in clinic or via remote monitoring) to -   \n      * monitor for HV lead noise using an unused EGM channel  \n      * turn on RV AutoCapture\u2122 (or equivalent) pacing to monitor pacing thresholds\u00a0  \n    * and at six-month intervals (in clinic) to -   \n      * ensure high voltage lead integrity (HVLI) \u00a0testing is performed.  \n  * At box change, if a decision is made to continue to use the lead, ensure that the replacement device has remote/advanced monitoring capabilities.  \n  * Consider the need for further examination e.g. by ECG or fluoroscopy*, if a lead failure is suspected.  \n  * If a lead failure is confirmed, the risks and benefits of lead replacement options should be evaluated on a case-by-case basis in discussion with the patient.  \n  \nNote: Prophylactic lead explantation is not recommended, other than in exceptional clinical circumstances.\n\n* In all cases, the benefit of fluoroscopic screening should be weighed against the risks from radiation exposure on an individual patient basis, in line with the requirements of The Ionising Radiation (Medical Exposure) Regulations 2000.\n\nFurther advice  \n  \n  * Where appropriate for patients, follow-up should continue to include:  \n> provocative testing (e.g. shoulder/arm movements and deep respiration), which may help reveal an\u00a0\u00a0 intermittent problem  \n> increasing the detection time of the VT zone to reduce the risk of oversensing and inappropriate  \nshocks  \n> ensuring the SVT discriminators are on, where applicable  \n> ensuring that the lead impedance alarms are programmed on.  \n  * Remind patients of the importance of contacting their follow-up clinic as soon as possible in the event of therapy delivery and/or the onset of any patient alert.  \n  * Report all lead adverse incidents to the MHRA and to St Jude Medical.  \n  \n### Action by\n\nAll cardiologists and cardiac physiologists who manage patients implanted with ICD leads.\n\n## Distribution\n\nThis MDA has been sent to: \u00a0  \n  \n  * NHS trusts in England (chief executives)  \n  * Care Quality Commission (CQC) (Headquarters) for information  \n  * HSC trusts in Northern Ireland (chief executives)  \n  * NHS boards in Scotland (equipment coordinators)  \n  * NHS boards and trusts in Wales (chief executives)  \n  \n### Onward distribution\n\nPlease bring this notice to the attention of relevant employees in your establishment. \u00a0Below is a suggested list of recipients.\n\nTrusts  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * Cardiac laboratory technicians  \n  * Cardiac pacing technicians  \n  * Cardiac physiologists  \n  * Cardiologists  \n  * Cardiothoracic surgeons  \n  * Clinical governance leads  \n  * Medical directors  \n  * Nursing executive directors  \n  \n### Independent distribution\n\nEstablishments registered with the Care Quality Commission (CQC) (England only)  \nThis alert should be read by:  \n  \n  * Hospitals in the independent sector  \n  * Private medical practitioners  \n  \nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health\u2019s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk)\u00a0and requesting this facility.\n\n## Manufacturer Contact\n\nSt Jude Medical UK Ltd  \nSean Hogarth  \nCapulet House  \nStratford Business and Technology Park\u00a0  \nStratford Upon Avon\u00a0  \nCV37 7GX\u00a0\n\nTel: 01789 207 600\u00a0  \nFax: 01789 207 601\n\nEmail:\u00a0 [shogarth@sjm.com](mailto:shogarth@sjm.com)\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk)\n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2012/061 or 2012/007/020/081/010\n\nTechnical aspects  \nMichelle Kelly or Simon Holmes  \nMedicines & Healthcare products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0020 3080 7145 or 7240  \nFax:\u00a0020 8754 3965  \nEmail:\u00a0[michelle.kelly@mhra.gsi.gov.uk](mailto:michelle.kelly@mhra.gsi.gov.uk) or [simon.holmes@mhra.gsi.gov.uk](mailto:simon.holmes@mhra.gsi.gov.uk)\n\nClinical aspects  \nDr Nicola Lennard  \nMedicines & Healthcare products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0020 3080 7126  \nFax:\u00a0020 8754 3965  \nEmail:\u00a0[nicola.lennard@mhra.gsi.gov.uk](mailto:nicola.lennard@mhra.gsi.gov.uk)\n\n### How to report adverse incidents\n\nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \nFurther information about CAS can be found [on the CAS website](https://www.cas.dh.gov.uk/Home.aspx) (external link)\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings  \nStormont Estate  \nDundonald BT4 3SQ\n\nTel: 02890 523 704  \nFax: 02890 523 900  \nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n### How to report adverse incidents in Northern Ireland\n\nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link)  \nFurther information about SABS can be found [on the SABS website](http://sabs.dhsspsni.gov.uk/)(external link)\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\nIncident Reporting and Investigation Centre  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh EH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link)\n\n## Wales\n\nEnquiries in Wales should be addressed to:  \n  \nImproving Patient Safety Team  \nMedical Directorate  \nWelsh Assembly Government  \nCathays Park  \nCardiff CF10 3NQ\n\nTel: 029 2082 3922  \nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><span>Implantable cardioverter defibrillator (ICD) leads.<br>\n<br>\nRiata and Riata ST &#8211; all silicone coated models.<br>\n<br>\nManufactured by St Jude Medical.</span></p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p>Risk of inappropriate shock or therapy failure due to wear of lead insulation after implantation.</p>\n\n<p>These patient follow-up recommendations replace those given previously in MDA/2010/095 and MDA/2011/112.</p>\n\n<p>In December 2011, the MHRA issued a Medical Device Alert (MDA/2011/112) recommending enhanced patient follow-up for all patients implanted with Riata and Riata ST lead models. At that time the frequency of follow-up was stratified according to lead model. Current evidence suggests that the difference in prevalence of externalised cables between 8Fr and 7Fr lead models is decreasing.</p>\n\n<p>St Jude Medical has recently issued a <a href=\"#ASSET0\">ASSET_TAG</a> (155Kb) (dated 13 July 2012) detailing phase I of a Riata lead evaluation study to investigate the prevalence of externalised cables using fluoroscopy. The clinical significance of externalised cables will not, however, be evident until phase II of the study is completed; this is unlikely to be before the end of 2013. For this reason this Medical Device Alert is focusing on detection of early signs of functional lead failure, as these lead models continue to fail at a higher rate.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<ul>\n<li>Continue to follow up all patients implanted with Riata or Riata ST ICD lead models to identify any changes in lead performance, according to your own standard procedures (see further advice below). Undertake this: \n\n<ul>\n<li>at three-month intervals (in clinic or via remote monitoring) to - \n\n<ul>\n<li>monitor for HV lead noise using an unused EGM channel</li>\n\n<li>turn on RV AutoCapture&#8482; (or equivalent) pacing to monitor pacing thresholds&#160;</li>\n</ul>\n</li>\n\n<li>and at six-month intervals (in clinic) to - \n\n<ul>\n<li>ensure high voltage lead integrity (HVLI) &#160;testing is performed.</li>\n</ul>\n</li>\n</ul>\n</li>\n\n<li>At box change, if a decision is made to continue to use the lead, ensure that the replacement device has remote/advanced monitoring capabilities.</li>\n\n<li>Consider the need for further examination e.g. by ECG or fluoroscopy*, if a lead failure is suspected.</li>\n\n<li>If a lead failure is confirmed, the risks and benefits of lead replacement options should be evaluated on a case-by-case basis in discussion with the patient.</li>\n</ul>\n\n<p><span>Note:</span> Prophylactic lead explantation is not recommended, other than in exceptional clinical circumstances.</p>\n\n<p>* In all cases, the benefit of fluoroscopic screening should be weighed against the risks from radiation exposure on an individual patient basis, in line with the requirements of The Ionising Radiation (Medical Exposure) Regulations 2000.</p>\n\n<p><span>Further advice</span></p>\n\n<ul>\n<li>Where appropriate for patients, follow-up should continue to include:<br style=\" margin-left: 40.0px;\">\n&gt; provocative testing (e.g. shoulder/arm movements and deep respiration), which may help reveal an&#160;&#160; intermittent problem<br style=\" margin-left: 40.0px;\">\n&gt; increasing the detection time of the VT zone to reduce the risk of oversensing and inappropriate<br style=\" margin-left: 40.0px;\">\nshocks<br style=\" margin-left: 40.0px;\">\n&gt; ensuring the SVT discriminators are on, where applicable<br style=\" margin-left: 40.0px;\">\n&gt; ensuring that the lead impedance alarms are programmed on.</li>\n\n<li>Remind patients of the importance of contacting their follow-up clinic as soon as possible in the event of therapy delivery and/or the onset of any patient alert.</li>\n\n<li>Report all lead adverse incidents to the MHRA and to St Jude Medical.</li>\n</ul>\n\n<h3>Action by</h3>\n\n<p>All cardiologists and cardiac physiologists who manage patients implanted with ICD leads.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been sent to: &#160;</p>\n\n<ul>\n<li>NHS trusts in England (chief executives)</li>\n\n<li>Care Quality Commission (CQC) (Headquarters) for information</li>\n\n<li>HSC trusts in Northern Ireland (chief executives)</li>\n\n<li>NHS boards in Scotland (equipment coordinators)</li>\n\n<li>NHS boards and trusts in Wales (chief executives)</li>\n</ul>\n\n<h3>Onward distribution</h3>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment. &#160;Below is a suggested list of recipients.</p>\n\n<p><span>Trusts</span><br>\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>Cardiac laboratory technicians</li>\n\n<li>Cardiac pacing technicians</li>\n\n<li>Cardiac physiologists</li>\n\n<li>Cardiologists</li>\n\n<li>Cardiothoracic surgeons</li>\n\n<li>Clinical governance leads</li>\n\n<li>Medical directors</li>\n\n<li>Nursing executive directors</li>\n</ul>\n\n<h3>Independent distribution</h3>\n\n<p><span>Establishments registered with the Care Quality Commission (CQC) (England only)</span><br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Hospitals in the independent sector</li>\n\n<li>Private medical practitioners</li>\n</ul>\n\n<p>Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health&#8217;s Central Alerting System (CAS) by sending an email to: <a href=\"mailto:safetyalerts@dh.gsi.gov.uk\" added=\"null\">safetyalerts@dh.gsi.gov.uk</a>&#160;and requesting this facility.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\t<p>St Jude Medical UK Ltd<br>\nSean Hogarth<br>\nCapulet House<br>\nStratford Business and Technology Park&#160;<br>\nStratford Upon Avon&#160;<br>\nCV37 7GX&#160;</p>\n\n<p>Tel: 01789 207 600&#160;<br>\nFax: 01789 207 601</p>\n\nEmail:&#160; <a href=\"mailto:shogarth@sjm.com\">shogarth@sjm.com</a>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\t<p>If you have any comments or feedback on this Medical Device Alert please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\" added=\"null\">dts@mhra.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2012/061</span> or <span>2012/007/020/081/010</span></p>\n\n<p><span>Technical aspects</span><br>\nMichelle Kelly or Simon Holmes<br>\nMedicines &amp; Healthcare products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;020 3080 7145 or 7240<br>\nFax:&#160;020 8754 3965<br>\nEmail:&#160;<a href=\"mailto:michelle.kelly@mhra.gsi.gov.uk\">michelle.kelly@mhra.gsi.gov.uk</a> or <a href=\"mailto:simon.holmes@mhra.gsi.gov.uk\">simon.holmes@mhra.gsi.gov.uk</a></p>\n\n<p><span>Clinical aspects</span><br>\nDr Nicola Lennard<br>\nMedicines &amp; Healthcare products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;020 3080 7126<br>\nFax:&#160;020 8754 3965<br>\nEmail:&#160;<a href=\"mailto:nicola.lennard@mhra.gsi.gov.uk\">nicola.lennard@mhra.gsi.gov.uk</a></p>\n\n<h3>How to report adverse incidents</h3>\n\n<p>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\" added=\"null\">Reporting adverse incidents involving medical devices</a><br>\nFurther information about CAS can be found <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\" added=\"null\">on the CAS website</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<p>Northern Ireland Adverse Incident Centre<br>\nHealth Estates Investment Group<br>\nRoom 17<br>\nAnnex 6<br>\nCastle Buildings<br>\nStormont Estate<br>\nDundonald BT4 3SQ</p>\n\n<p>Tel: 02890 523 704<br>\nFax: 02890 523 900<br>\nEmail: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\" added=\"null\">NIAIC@dhsspsni.gov.uk</a></p>\n\n<h3>How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" added=\"null\">NIAIC website</a> (external link)<br>\nFurther information about SABS can be found <a href=\"http://sabs.dhsspsni.gov.uk/\" added=\"null\">on the SABS website</a>(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<p>Incident Reporting and Investigation Centre<br>\nHealth Facilities Scotland<br>\nNHS National Services Scotland<br>\nGyle Square<br>\n1 South Gyle Crescent<br>\nEdinburgh EH12 9EB</p>\n\n<p>Tel: 0131 275 7575<br>\nFax: 0131 314 0722</p>\n\n<p>Email: <a href=\"mailto:nss.iric@nhs.net\" added=\"null\">nss.iric@nhs.net</a></p>\n\n<p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\" added=\"null\">Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)<font class=\"trianglelink\">Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)</font></a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:<br>\n<br>\nImproving Patient Safety Team<br>\nMedical Directorate<br>\nWelsh Assembly Government<br>\nCathays Park<br>\nCardiff CF10 3NQ</p>\n\n<p>Tel: 029 2082 3922<br>\nEmail: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\" added=\"null\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: Implantable cardioverter defibrillator (ICD) leads Manufactured by St Jude Medical (MDA/2012/061)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": [
    "cardiology", 
    "vascular-cardiac-surgery"
  ]
}